CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Bu Gyeom Kim

OPENALEX: A5075701011↗ORCID: 0000-0002-3793-7847↗

Affiliations

Organizations

Korea Universityauthorship · KR Korea University Medical Centerauthorship · KR

Public evidence

4 connected articles

Synergistic Anticancer Effects of Fibroblast Growth Factor Receptor Inhibitor and Cannabidiol in Colorectal Cancer.2025 · Europe PMC Cannabidiol Suppresses Angiogenesis and Stemness of Breast Cancer Cells by Downregulation of Hypoxia-Inducible Factors-1α.2021 · Europe PMC Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer.2019 · PubMed Central Open Access Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer.2019 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Bu Gyeom Kim - Medical Cannabis Research Engine